References
- Bange J, Zwick E, Ullrich A. Molecular targets for breast cancer therapy and prevention. Nat Med 2001;7:548–52
- Ghorab MM, Alsaid MS, Ceruso M, et al. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties. Bioorg Med Chem 2014;22:3684–95
- Carta F, Supuran CT, Scozzafava A. Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med Chem 2014;6:1149–65
- Supuran CT, Scozzafava A, Inventors. Carbonic anhydrase inhibitors and their therapeutic potential. Exp Opin Ther Patents 2000;10:575–600
- Casini A, Scozzafava A, Mastrolorenzo A, Supuran CT. Sulfonamides and sulfonylated derivatives as anticancer agents. Curr Cancer Drug Targets 2002;2:55–75
- Bano S, Javed K, Ahmad S, et al. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur J Med Chem 2011;46:5763–8
- Altisen RC, Constansa JF, Bafalluy RM, Rigat IC. Inventors. Substituted pyrazoline derivatives. 2005;US patent 0182119A1
- Bansal R, Narang G, Zimmer C, Hartmann RW. Synthesis of some imidazolyl-substituted 2-benzylidene indanone derivatives as potent aromatase inhibitors for breast cancer therapy. Med Chem Res 2011;20:661–9
- Saxena HO, Faridi U, Kumar JK, et al. Synthesis of chalcone derivatives on steroidal framework and their anticancer activities. Steroids 2007;72:892–900
- Saxena HO, Faridi U, Srivastava S, et al. Gallic acid-based indanone derivatives as anticancer agents. Bioorg Med Chem Lett 2008;18:3914–18
- Chanda D, Bhushan S, Guru SK, et al. Anticancer activity, toxicity and pharmacokinetic profile of an indanone derivative. Eur J Pharm Sci 2012;47:988–95
- Zhou DY, Ding N, Zhao SQ, et al. Synthesis and evaluation of curcumin-related compounds containing inden-2-one for their effects on human cancer cells. Biol Pharm Bull 2014;37:1977–81
- Tugrak M, Gul HI, Sakagami H. Synthesis and cytotoxicities of 2-[4-hydroxy-(3,5-bis-aminomethyl)-benzylidene]-indan-1-ones. Lett Drug Des Discov 2015;12:806–12
- Tugrak M, Yamali C, Sakagami H, Gul HI. Synthesis of mono Mannich bases of 2-(4-hydroxybenzylidene)-2,3-dihydroinden-1-one and evaluation of their cytotoxicities. J Enzyme Inhib Med Chem 2015;6:1–6
- Yamali C, Tugrak M, Gul HI, et al. The inhibitory effects of phenolic Mannich bases on carbonic anhydrase I and II isoenzymes. J Enzyme Inhib Med Chem 2016;10:1–4
- Rizzo S, Bartolini M, Ceccarini L, et al. Targeting Alzheimer's disease: novel indanone hybrids bearing a pharmacophoric fragment of AP2238. Bioorg Med Chem 2010;18:1749–60
- Vaskova J, Reisch R, Vasko L, et al. Effect of selected dimethylaminochalcones on some mitochondrial activities. In Vitro Cell Dev Biol Anim 2013;49:354–9
- Yerdelen KO, Gul HI, Sakagami H, Umemura N. Synthesis and biological evaluation of 1,5-bis(4-hydroxy-3-methoxyphenyl)penta-1,4-dien-3-one and its aminomethyl derivatives. J Enzyme Inhib Med Chem 2015;30:383–8
- Yerdelen KO, Gul HI, Sakagami H, et al. Synthesis and cytotoxic activities of a curcumin analogue and its bis-Mannich derivatives. Lett Drug Des Discov 2015;12:643–9
- Bilginer S, Gul HI, Mete E, et al. 1-(3-Aminomethyl-4-hydroxyphenyl)-3-pyridinyl-2-propen-1-ones: A novel group of tumour-selective cytotoxins. J Enzyme Inhib Med Chem 2013;28:974–80
- Das U, Doroudi A, Gul HI, et al. Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells. Bioorg Med Chem 2010;18:2219–24
- Gul HI, Yerdelen KO, Das U, et al. Synthesis and cytotoxicity of novel 3-aryl-1-(3′-dibenzylaminomethyl-4′-hydroxyphenyl)-propenones and related compounds. Chem Pharm Bull 2008;56:1675–81
- Gul HI, Yerdelen KO, Gul M, et al. Synthesis of 4′-hydroxy-3′-piperidinomethylchalcone derivatives and their cytotoxicity against PC-3 cell lines. Arch Pharm (Weinheim) 2007;340:195–201
- Das U, Gul HI, Alcorn J, et al. Cytotoxic 5-aryl-1-(4-nitrophenyl)-3-oxo-1,4-pentadienes mounted on alicyclic scaffolds. Eur J Med Chem 2006;41:577–85
- Gul HI, Cizmecioglu M, Zencir S, et al. Cytotoxic activity of 4′-hydroxychalcone derivatives against Jurkat cells and their effects on mammalian DNA topoisomerase I. J Enzyme Inhib Med Chem 2009;24:804–7
- Bilginer S, Unluer E, Gul HI, et al. Carbonic anhydrase inhibitors. Phenols incorporating 2- or 3-pyridyl-ethenylcarbonyl and tertiary amine moieties strongly inhibit Saccharomyces cerevisiae beta-carbonic anhydrase. J Enzyme Inhib Med Chem 2014;29:495–9
- Sharma PK, Kumar S, Kumar P, et al. Synthesis of 1-(4-aminosulfonylphenyl)-3,5-diarylpyrazoline derivatives as potent antiinflammatory and antimicrobial agents. Med Chem Res 2012;21:2945–54
- Fioravanti R, Bolasco A, Manna F, et al. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors. Eur J Med Chem 2010;45:6135–8
- Turan-Zitouni G, Chevallet P, Kilic FS, Erol K. Synthesis of some thiazolyl-pyrazoline derivatives and preliminary investigation of their hypotensive activity. Eur J Med Chem 2000;35:635–41
- Reddy MV, Billa VK, Pallela VR, et al. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors. Bioorg Med Chem 2008;16:3907–16
- Sharma PK, Kumar S, Kumar P, et al. Synthesis and biological evaluation of some pyrazolylpyrazolines as anti-inflammatory-antimicrobial agents. Eur J Med Chem 2010;45:2650–5
- Sahu SK, Banerjee M, Samantray A, et al. Synthesis, analgesic, anti-inflammatory and antimicrobial activities of some novel pyrazoline derivatives. Trop J Pharm Res 2008;7:961–8
- Penning TD, Talley JJ, Bertenshaw SR, et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem 1997;40:1347–65
- Supuran CT. Carbonic anhydrase inhibitors: an editorial. Expert Opin Ther Pat 2013;23:677–9
- Hisar O, Beydemir S, Gulcin I, et al. Effects of low molecular weight plasma inhibitors of rainbow trout (Oncorhynchus mykiss) on human erythrocyte carbonic anhydrase-II isozyme activity in vitro and rat erythrocytes in vivo. J Enzyme Inhib Med Chem 2005;20:35–9
- Innocenti A, Gulcin I, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett 2010;20:5050–3
- Boztas M, Cetinkaya Y, Topal M, et al. Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties. J Med Chem 2015;58:640–50
- Scozzafava A, Supuran CT, Carta F. Antiobesity carbonic anhydrase inhibitors: a literature and patent review. Expert Opin Ther Pat 2013;23:725–35
- Carta F, Supuran CT. Diuretics with carbonic anhydrase inhibitory action: a patent and literature review. Expert Opin Ther Pat 2013;23:681–91
- Sabitha G, Reddy GSKK, Reddy KB, Yadav JS. Iodotrimethylsilane-mediated cross-aldol condensation: a facile synthesis of alpha, alpha '-bis(substituted benzylidene)cycloalkanones. Synthesis 2004;2:263–6.
- Dimmock JR, Kandepu NM, Hetherington M, et al. Cytotoxic activities of Mannich bases of chalcones and related compounds. J Med Chem 1998;41:1014–26
- Tamura N, Hirano K, Kishino K, et al. Analysis of type of cell death induced by topoisomerase inhibitor SN-38 in human oral squamous cell carcinoma cell lines. Anticancer Res 2012;32:4823–32
- Sakagami H, Shimada C, Kanda Y, et al. Effects of 3-styrylchromones on metabolic profiles and cell death in oral squamous cell carcinoma cells. Toxocol Rep 2015;2:1281–90
- Topal M, Gulcin I. Rosmarinic acid: a potent carbonic anhydrase isoenzymes inhibitor. Turk J Chem 2014;38:894–902
- Cetinkaya Y, Gocer H, Gulcin I, Menzek A. Synthesis and carbonic anhydrase isoenzymes inhibitory effects of brominated diphenylmethanone and its derivatives. Arch Pharm (Weinheim) 2014;347:354–9
- Akincioglu A, Topal M, Gulcin I, Goksu S. Novel sulphamides and sulphonamides incorporating the tetralin scaffold as carbonic anhydrase and acetylcholine esterase inhibitors. Arch Pharm (Weinheim) 2014;347:68–76
- Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221–9
- Cetinkaya Y, Gocer H, Goksu S, Gulcin I. Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives. J Enzyme Inhib Med Chem 2014;29:168–74
- Akbaba Y, Akincioglu A, Gocer H, et al. Carbonic anhydrase inhibitory properties of novel sulfonamide derivatives of aminoindanes and aminotetralins. J Enzyme Inhib Med Chem 2014;29:35–42
- Gulcin I, Kufrevioglu OI, Oktay M. Purification and characterization of polyphenol oxidase from nettle (Urtica dioica L.) and inhibitory effects of some chemicals on enzyme activity. J Enzyme Inhib Med Chem 2005;20:297–302
- Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–5
- Aksu K, Nar M, Tanc M, et al. Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine. Bioorg Med Chem 2013;21:2925–31
- Akincioglu A, Akbaba Y, Gocer H, et al. Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors. Bioorg Med Chem 2013;21:1379–85
- Gulcin I, Beydemir S. Phenolic compounds as antioxidants: carbonic anhydrase isoenzymes inhibitors. Mini Rev Med Chem 2013;13:408–30
- Atasever A, Ozdemir H, Gulcin I, Irfan Kufrevioglu O. One-step purification of lactoperoxidase from bovine milk by affinity chromatography. Food Chem 2013;136:864–70
- Nar M, Cetinkaya Y, Gulcin I, Menzek A. (3,4-Dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and its derivatives as carbonic anhydrase isoenzymes inhibitors. J Enzyme Inhib Med Chem 2013;28:402–6
- Ozturk Sarikaya SB, Topal F, Senturk M, et al. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds. Bioorg Med Chem Lett 2011;21:4259–62